InvestSMART

Nyrada Inc (ASX: NYR) - Share Price

- Current share price for NYR : $0.430

Nyrada Inc (NYR), an ASX-listed company, is a clinical-stage biotechnology company focused on the discovery and development of small-molecule therapies, specifically targeting Transient Receptor Potential Canonical (TRPC) ion channels.

NYR General Information +

ASX Code NYR
Website http://www.nyrada.com
Industry/Sector Pharmaceuticals
Market Cap ($M) 105
NYR Share Price $0.430
Day High $0.458
Day Low $0.430
Last Close $0.430
NYR Share Price Movement - ( No change )
Prices as at 16:40, 16 Jun 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Nyrada Inc (NYR) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Nyrada Inc (NYR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Nyrada Inc (NYR) price-sensitive announcements

NYR - Xolatryp Enhances Anthracycline Anti-Tumour Efficacy
Nyrada Inc, an Australian biotechnology company, announced the promising preclinical resul
Nyrada Inc (NYR)
20 May 2026 | 9:13 AM
NYR - Trading Halt
Nyrada Inc., a clinical-stage biotechnology company, has requested a trading halt on the A
Nyrada Inc (NYR)
19 May 2026 | 4:54 PM
NYR - Pause in Trading
On 19 May 2026, the Australian Securities Exchange (ASX) announced a temporary pause in tr
Nyrada Inc (NYR)
19 May 2026 | 3:37 PM
NYR - Nyrada Receives Notice of Allowance for Xolatryp US Patent
Nyrada Inc, a clinical-stage biotechnology company, announced the receipt of a notice of a
Nyrada Inc (NYR)
19 May 2026 | 3:10 PM

Nyrada Inc (NYR) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Nyrada Inc (NYR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $106 Cleansing Statement 16 Jun 2026 4:42PM $0.430 $0.430 fallen by 0%
Nyrada Inc (NYR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $106 Application for quotation of securities - NYR 16 Jun 2026 4:39PM $0.430 $0.430 fallen by 0%
Nyrada Inc (NYR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $106 Change of Director's Interest Notice - JB 16 Jun 2026 8:25AM $0.440 $0.430 fallen by 2.27%
Nyrada Inc (NYR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $106 PROTECT-MI Phase IIa Clinical Trial Update 16 Jun 2026 8:24AM $0.440 $0.430 fallen by 2.27%
Nyrada Inc (NYR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $106 Investor Presentation 4 Jun 2026 9:39AM $0.450 $0.430 fallen by 4.44%
Nyrada Inc (NYR)
CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED
Health Care $106 Nyrada Successfully Completes Cardioprotection Pilot Study 3 Jun 2026 1:39PM $0.450 $0.430 fallen by 4.44%

NYR Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$4.85 -$2.40 184.70% 0.00 0.00 0.00% 0.0%
2024A -$1.39 -$0.90 -83.00% 0.00 0.00 0.00% 0.0%
2023A -$7.78 -$5.00 96.50% 0.00 0.00 0.00% 0.0%

NYR Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Clarity Pharmaceuticals Ltd (CU6) $835M 0.3002 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $1,636M -0.7857 0.0743 1.2000 55.6511 51.8000 23.5455 0.00% 0.00% 0.00%
Nyrada Inc (NYR) $108M 1.8471 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

NYR Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 25.30 0.00
Market 0.30 13.20 1.18 0.68
Sector 0.40 27.30 2.51 2.19

NYR Directors

Name Position Start Date
Mr James Bonnar Chief Executive Officer, Managing Director 8 Oct 2025
Dr Ian Edward Dixon Founder, Non-Executive Director 8 Sep 2020
Mr John Alexander Moore Non-Executive Chairman, Non-Executive Director 4 Jun 2019
Mr Ruediger Weseloh Non-Executive Director 4 Jun 2019
Mr Christopher Cox Non-Executive Director 7 Nov 2019
Mr Marcus Frampton Non-Executive Director 4 Jun 2019

Nyrada Inc (NYR) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
9 Mar 2026 MOORE, John Buy Direct Shares 1,000,000 $0.540 $540,000.000
18 Dec 2025 DIXON, Ian Sell Indirect Shares 600,000 $0.646 $387,600.000
10 Dec 2025 MOORE, John Buy Direct Shares 1,200,000 $0.200 $240,000.000

See all changes in directors' interest & trades for Nyrada Inc (NYR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

NYR Management

Name Position
David James Franks Company Secretary

NYR Calendar of Events

Date Event
17 February 2027 Report (Interim)
21 August 2026 Report (Annual)
21 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.